20-18393809-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001367614.1(DZANK1):āc.1786A>Gā(p.Ser596Gly) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000261 in 1,607,746 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001367614.1 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DZANK1 | NM_001367614.1 | c.1786A>G | p.Ser596Gly | missense_variant, splice_region_variant | 17/21 | ENST00000699568.1 | NP_001354543.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DZANK1 | ENST00000699568.1 | c.1786A>G | p.Ser596Gly | missense_variant, splice_region_variant | 17/21 | NM_001367614.1 | ENSP00000514442.1 | |||
DZANK1 | ENST00000699590.1 | c.1744A>G | p.Ser582Gly | missense_variant, splice_region_variant | 17/21 | ENSP00000514461.1 | ||||
DZANK1 | ENST00000699525.1 | c.1729A>G | p.Ser577Gly | missense_variant, splice_region_variant | 17/21 | ENSP00000514418.1 | ||||
DZANK1 | ENST00000357236.8 | c.1132A>G | p.Ser378Gly | missense_variant, splice_region_variant | 13/17 | 5 | ENSP00000349774.5 | |||
DZANK1 | ENST00000480488.2 | c.325A>G | p.Ser109Gly | missense_variant, splice_region_variant | 6/6 | 5 | ENSP00000484666.1 | |||
DZANK1 | ENST00000377630.9 | n.*917A>G | splice_region_variant, non_coding_transcript_exon_variant | 16/20 | 2 | ENSP00000366857.6 | ||||
DZANK1 | ENST00000377630.9 | n.*917A>G | 3_prime_UTR_variant | 16/20 | 2 | ENSP00000366857.6 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000326 AC: 8AN: 245468Hom.: 0 AF XY: 0.0000225 AC XY: 3AN XY: 133080
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1455448Hom.: 0 Cov.: 29 AF XY: 0.0000180 AC XY: 13AN XY: 724046
GnomAD4 genome AF: 0.000131 AC: 20AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.1711A>G (p.S571G) alteration is located in exon 17 (coding exon 16) of the DZANK1 gene. This alteration results from a A to G substitution at nucleotide position 1711, causing the serine (S) at amino acid position 571 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at